Wiley Bros. Aintree Capital, LLC Abbott Laboratories Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 107,790 shares of ABT stock, worth $12.3 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
107,790
Previous 22,840
371.94%
Holding current value
$12.3 Million
Previous $2.6 Million
331.6%
% of portfolio
0.5%
Previous 0.36%
Shares
15 transactions
Others Institutions Holding ABT
# of Institutions
3,131Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.47 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.18 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.52 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...